Related Experiment Video
Updated: Feb 12, 2026
Investigating Migraine-Like Behavior Using Light Aversion in Mice
Published on: August 11, 2021
Almotriptan: a novel 5-HT1B/D agonist for the symptomatic treatment of migraine
1Service of Neurology, University Hospital, "Marqués de Valdecilla", 39008 Santander, Spain. pascualj@unican.es
Abstract:
Currently available oral triptans are not ideal, at least for 20-30% of migraine patients, due to either response failure or adverse events. Almotriptan is a novel selective 5-HT1B/D receptor agonist exhibiting the highest bioavailability among triptans, both outside and within a migraine attack. The tolerability of the therapeutic oral dose of almotriptan, 12.5 mg, is similar to that of placebo, with a remarkably low incidence of chest symptoms. At this dose, efficacy parameters remain comparable to those of sumatriptan 100 mg, while the recurrence rate is in the lower range. This balanced profile makes almotriptan 12.5 mg a good choice for the symptomatic treatment of the typical migraine patient.
Related Concept Videos
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
01:045-Number Summary
In a box plot, the minimum and maximum data values represent the lower and upper whiskers in the graph, and the median is designated as the center of the box in the chart. The first quartile and third...
01:30Adrenergic Agonists: Therapeutic Uses
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
01:24Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
01:25Drug-Receptor Interaction: Agonist
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
01:18Adrenergic Agonists: Therapeutic Classification
Vasopressor or pressor agents: They increase blood pressure and function as cardiac stimulants. Examples include endogenous catecholamines (norepinephrine and dopamine) and synthetic agents (phenylephrine).
Bronchodilators: β2-agonists can relax bronchial muscles and widen airways. They are commonly used for treating obstructive pulmonary...